These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens. Pollini S, Brunetti J, Sennati S, Rossolini GM, Bracci L, Pini A, Falciani C. J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481 [Abstract] [Full Text] [Related]
3. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles. van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, Kreft D, Ten Kate MT, Falciani C, Pini A, Strandh M, Bakker-Woudenberg IAJM, Hays JP, Goessens WHF. Int J Antimicrob Agents; 2019 Aug; 54(2):159-166. PubMed ID: 31173867 [Abstract] [Full Text] [Related]
4. Spectroscopic investigations of the binding mechanisms between antimicrobial peptides and membrane models of Pseudomonas aeruginosa and Klebsiella pneumoniae. Chai H, Allen WE, Hicks RP. Bioorg Med Chem; 2014 Aug 01; 22(15):4210-22. PubMed ID: 24931276 [Abstract] [Full Text] [Related]
6. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators. Hussein MH, Schneider EK, Elliott AG, Han M, Reyes-Ortega F, Morris F, Blastovich MAT, Jasim R, Currie B, Mayo M, Baker M, Cooper MA, Li J, Velkov T. Microb Drug Resist; 2017 Jul 01; 23(5):640-650. PubMed ID: 27935770 [Abstract] [Full Text] [Related]
9. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae. Lee MY, Ko KS, Song JH, Peck KR. J Antimicrob Chemother; 2007 Oct 01; 60(4):782-7. PubMed ID: 17681978 [Abstract] [Full Text] [Related]
10. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Int J Antimicrob Agents; 2005 Jan 01; 25(1):11-25. PubMed ID: 15620821 [Abstract] [Full Text] [Related]
15. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates. Choi MJ, Park YK, Peck KR, Ko KS. Int J Antimicrob Agents; 2014 Nov 15; 44(5):475-6. PubMed ID: 25443890 [No Abstract] [Full Text] [Related]
17. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]. Zarakolu P, Hasçelik G, Unal S. Mikrobiyol Bul; 2006 Jul 15; 40(3):147-54. PubMed ID: 17001842 [Abstract] [Full Text] [Related]
18. Phytantriol-Based Cubosome Formulation as an Antimicrobial against Lipopolysaccharide-Deficient Gram-Negative Bacteria. Lai X, Ding Y, Wu CM, Chen X, Jiang JH, Hsu HY, Wang Y, Le Brun AP, Song J, Han ML, Li J, Shen HH. ACS Appl Mater Interfaces; 2020 Oct 07; 12(40):44485-44498. PubMed ID: 32942850 [Abstract] [Full Text] [Related]
19. Polydim-I antimicrobial activity against MDR bacteria and its model membrane interaction. Rangel M, Castro FFDS, Mota-Lima LD, Clissa PB, Martins DB, Cabrera MPDS, Mortari MR. PLoS One; 2017 Oct 07; 12(6):e0178785. PubMed ID: 28570651 [Abstract] [Full Text] [Related]
20. Enhanced Silkworm Cecropin B Antimicrobial Activity against Pseudomonas aeruginosa from Single Amino Acid Variation. Romoli O, Mukherjee S, Mohid SA, Dutta A, Montali A, Franzolin E, Brady D, Zito F, Bergantino E, Rampazzo C, Tettamanti G, Bhunia A, Sandrelli F. ACS Infect Dis; 2019 Jul 12; 5(7):1200-1213. PubMed ID: 31045339 [Abstract] [Full Text] [Related] Page: [Next] [New Search]